Allergan, Sosei halt Alzheimer’s trials amid safety scare

Discussion in 'Pharma/Biotech Companies - In the News' started by cafead, Sep 18, 2018 at 10:22 AM.

  1. #1 cafead, Sep 18, 2018 at 10:22 AM
    cafead

    cafead Administrator
    Staff Member

    Joined:
    Nov 21, 2001
    Messages:
    32,962
    Likes Received:
    3
    via Allergan and Sosei have voluntarily paused development of HTL0018318 after tests in nonhuman primates uncovered unexpected toxicology findings. Phase 1 and 2 clinical trials of the muscarinic M1 receptor agonist are on hold while the partners investigate the toxicology results.

    article source
     
    Quote

Reply to Thread